Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 1, 2008, Pages 432-435

  Thimmegowda, N R ^a   Nanjunda Swamy, S ^a,c   Ananda Kumar, C S ^a   Sunil Kumar, Y C ^a   Chandrappa, S ^a   Yip, George W ^b   Rangappa, K S ^a  

^a UNIVERSITY OF MYSORE   (India)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SRI JAYACHAMARAJENDRA COLLEGE OF ENGINEERING   (India)

Author keywords

Cell proliferation; MDA MB 231; Trisubstituted benzimidazole

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; N [4 CYANO 3 (TRIFLUOROMETHYL)PHENYL] 4 FLUORO 3 NITROBENZAMIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CELL PROLIFERATION; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 37549070741     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.08.078     Document Type: Article

References (38)

1. Spasov A.R., Iezhitsa I.N., Bugaeva L.I., and Anisimova V.A. Khim.-Farm. Zhurn. 33 (1999) 6
2. Grassmann S., Sadek B., Ligneau X., Elz S., Ganellin C.R., Arrang J.M., Schwartz J.C., Stark H., and Schunack W. Eur. J. Pharm. Sci. 15 (2002) 367
3. Al Muhaimeed H. J. Int. Med. Res. 25 (1997) 175
4. Richter J.E. Am. J. Gastroenterol. 92 (1997) 34
5. Labanauskas L.K., Brukstus A.B., Gaidelis P.G., Buchinskaite V.A., Udrenaite E.B., and Dauksas V.K. Pharm. Chem. J. 34 (2000) 353
6. Sondhi S.M., Rajvanshi S., Johar M., Bharti N., Azam A., and Singh A.K. Eur. J. Med. Chem. 37 (2002) 835
7. Sondhi S.M., Singhal N., Johar M., Reddy B.S., and Lown J.W. Curr. Med. Chem. 9 (2002) 1045
8. Sondhi S.M., Singh N., Johar M., and Kumar A.. Bioorg. Med. Chem. 13 (2005) 6158
9. Sondhi S.M., Goyal R.N., Lahoti A.M., Singh N., Shukla R., and Raghubir R. Bioorg. Med. Chem. 13 (2005) 3185
10. Can-Eke B., Puskullu M.O., Buyukbingol E., and Iscan M. Chem.-Biol. Interact. 113 (1998) 65
11. Evans T.M., Gardiner J.M., Mahmood N., and Smis M. Bioorg. Med. Chem. Lett. 7 (1997) 409
12. Novelli F., Tasso B., Sparatore F., and Sparatore A. Chem. Abstr. 128 (1998) 238983j
13. Bell C.A., Dykstra C.C., Naiman N.A., Cory M., Fairley T.A., and Tidwell R.R. Antimicrob. Agents Chemother. 37 (1993) 2668
14. Klimesova V., Koci J., Pour M., Stachel J., Waisser K., and Kaustova J. Eur. J. Med. Chem. 37 (2002) 409
15. Kumar B.V., Vaidya S.D., Kumar R.V., Bhirud S.B., and Mane R.B. Eur. J. Med. Chem. 41 (2006) 599
16. Arjmand F., Mohani B., and Ahmad S. Eur. J. Med. Chem. 40 (2005) 1103
17. He Y., Yang J., Wu B., Risen L., and Swayze E.E. Bioorg. Med. Chem. Lett. 14 (2004) 1217
18. He Y., Wu B., Yang J., Robinson D., Risen L., Ranken R., Blyn L., Sheng S., and Swayze E.E. Bioorg. Med. Chem. Lett. 13 (2003) 3253
19. Burli R.W., Jones P., McMinn D., Le Q., Duan J.X., Kaizerman J.A., Difuntorum S., and Moser H.E. Bioorg. Med. Chem. Lett. 14 (2004) 1259
20. Burli R.W., McMinn D., Kaizerman J.A., Hu W., Ge Y., Pack Q., Jiang V., Gross M., Garcia M., Tanaka R., and Moser H.E. Bioorg. Med. Chem. Lett. 14 (2004) 1253
21. Garuti L., Roberti M., Malagoli M., Rossi T., and Castelli M. Bioorg. Med. Chem. Lett. 10 (2000) 2193
22. Settimo A.D., Settimo F.D., Marini A.M., Primofiore G., Salerno S., Viola G., Vi L.D., and Magno S.M. Eur. J. Med. Chem. 33 (1998) 685
23. Beaulieu C., Wang Z., Denis D., Greig G., Lamontagne S., O'Neill G., Slipetz D., and Wang J. Bioorg. Med. Chem. Lett. 14 (2004) 3195
24. Nakano H., Inoue T., Kawasaki N., Miyataka H., Matsumoto H., Taguchi T., Inagaki N., Nagai H., and Satoh T. Bioorg. Med. Chem. 8 (2000) 373
25. White A.W., Curtin N.J., Eastman B.W., Golding B.T., Hostomsky Z., Kyle S., Li J., Maegley K.A., Skalitzky D.J., Webber S.E., Yu X.-H., and Griffin R.J. Bioorg. Med. Chem. Lett. 14 (2004) 2433
26. Lukevics E., Arsenyan P., Shestakova I., Domracheva I., Nesterova A., and Pudova O. Eur. J. Med. Chem. 36 (2001) 507
27. Huang X., Suleman A., and Skibo E.B. Bioorg. Chem. 28 (2000) 324
28. Sondhi S.M., Singh N., Lahoti A.M., Bajaj K., Kumar A., Lozech O., and Meijer L. Bioorg. Med. Chem. 13 (2005) 4291
29. Sondhi S.M., Singh N., Kumar A., Lozach O., and Meijer L. Bioorg. Med. Chem. 14 (2006) 3758
30. Demirayak S., Abu Mohsen U., and Caqri Karaburun A. Eur. J. Med. Chem. 37 (2002) 255
31. Huang S.T., Hsei I.J., and Chen C. Bioorg. Med. Chem. 14 (2006) 6106
32. Kumar C.C., Malkowski M., Yin Z., Tanghetti E., Yaremko B., Nechuta T., Varner J., Liu M., Smith E.M., Neustadt B., Presta M., and Armstrong L. Cancer Res. 61 (2001) 2232
33. White A.W., Almassy R., Calvert A.H., Curtin N.J., Griffin R.J., Hostomsky Z., Maegly K., Newell D.R., Srivinivasan S., and Golding B.T. J. Med. Chem. 43 (2000) 4084
34. Boiani M., and Gonzalez M. Mini-Rev. Med. Chem. 5 (2005) 409
35. Hori A., Imaeda Y., Kubo K., and Kusaka M. Cancer lett. 183 (2002) 53
36. 4O (in %): C, 61.68; H, 3.76; N,13.08. Found: C, 61.65; H, 3.72; N, 13.05.Synthesis of 3-(2,4-dichloro-benzoylamino)-N-(4-cyano-3-trifluoromethyl-phenyl)-4-(4- fluoro-benzylamino)- benzamide (6): The compound 5 (1.5 g, 3.5 mmol) in methylene dichloride (15 mL) and triethylamine (1.06 g, 10.50 mmol)
37. 38 Briefly, MDA-MB-231 cells were seeded onto the wells of 96-well plates at a density of 2000 cells/well. The test compounds at 2 mM final concentration in 1% DMSO were added and the cultures continued for 72 h. Replenishment with fresh compounds was done after the first 48 h. At the end of 72 h of treatment, the cultured medium was removed and 20 μl/well of combined MTS/PMS solution was added and incubated for 4 h. The absorbance at 490 nm was recorded using an ELISA plate reader.
38. Zou X.H., Foong W.C., Cao T., Bay B.H., Ouyang H.W., and Yip G.W. J. Dent. Res. 83 (2004) 880